Papillary thyroid microcarcinoma: optimal management versus overtreatment.

Area of Science:

• Endocrinology
• Oncology
• Surgical Oncology

Background:

• Papillary thyroid microcarcinoma treatment has evolved.
• Active surveillance is increasingly adopted over immediate surgery for low-risk cases.

Purpose of the Study:

• To review landmark trials supporting active surveillance for papillary thyroid microcarcinoma.
• To discuss patient selection, barriers, quality of life, and economic factors of active surveillance.

Main Methods:

• Literature review of landmark trials on active surveillance for papillary thyroid microcarcinoma.
• Analysis of patient factors (age, tumor size) and assessment criteria.
• Discussion of quality of life and economic implications.

Main Results:

• Active surveillance is a proven, viable first-line treatment for selected papillary microcarcinomas.
• Patient age and tumor size are key factors in selecting candidates for active surveillance.
• Quality of life and economic benefits are important considerations.

Conclusions:

• Active surveillance represents a paradigm shift in managing small, low-risk papillary thyroid cancers.
• Careful patient selection and addressing barriers are crucial for successful active surveillance implementation.
• Further research refines understanding of the clinical behavior of papillary microcarcinomas under active surveillance.